Correlation Between Zura Bio and Enliven Therapeutics
Can any of the company-specific risk be diversified away by investing in both Zura Bio and Enliven Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zura Bio and Enliven Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zura Bio Limited and Enliven Therapeutics, you can compare the effects of market volatilities on Zura Bio and Enliven Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zura Bio with a short position of Enliven Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zura Bio and Enliven Therapeutics.
Diversification Opportunities for Zura Bio and Enliven Therapeutics
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Zura and Enliven is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Zura Bio Limited and Enliven Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enliven Therapeutics and Zura Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zura Bio Limited are associated (or correlated) with Enliven Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enliven Therapeutics has no effect on the direction of Zura Bio i.e., Zura Bio and Enliven Therapeutics go up and down completely randomly.
Pair Corralation between Zura Bio and Enliven Therapeutics
Given the investment horizon of 90 days Zura Bio Limited is expected to under-perform the Enliven Therapeutics. In addition to that, Zura Bio is 2.06 times more volatile than Enliven Therapeutics. It trades about -0.41 of its total potential returns per unit of risk. Enliven Therapeutics is currently generating about -0.23 per unit of volatility. If you would invest 2,866 in Enliven Therapeutics on August 27, 2024 and sell it today you would lose (378.00) from holding Enliven Therapeutics or give up 13.19% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Zura Bio Limited vs. Enliven Therapeutics
Performance |
| Timeline |
| Zura Bio Limited |
| Enliven Therapeutics |
Zura Bio and Enliven Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Zura Bio and Enliven Therapeutics
The main advantage of trading using opposite Zura Bio and Enliven Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zura Bio position performs unexpectedly, Enliven Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enliven Therapeutics will offset losses from the drop in Enliven Therapeutics' long position.| Zura Bio vs. Scandinavian Tobacco Group | Zura Bio vs. United Airlines Holdings | Zura Bio vs. Saia Inc | Zura Bio vs. Mesa Air Group |
| Enliven Therapeutics vs. Capricor Therapeutics | Enliven Therapeutics vs. Soleno Therapeutics | Enliven Therapeutics vs. Bio Path Holdings | Enliven Therapeutics vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |